Announcement of the convening of the Ordinary General Meeting of Shareholders of READ-GENE S.A. as of June 30, 2023
The Board of READ-GENE S.A. with its registered office in Szczecin informs that it has decided to convene on the following day June 30, 2023, at 15:00 Ordinary General Meeting of Shareholders, which will take place in Szczecin at ul. 3 Maja 8/1 – Notary Office of Dobrosława Anna Kuniewicz.
The agenda of the Ordinary General Meeting of Shareholders will include:
Additional information
The Board of READ-GENE S.A. informs that by Art. 4061 – 4063 of the Commercial Companies Code, only persons who are shareholders of the Company sixteen days before the date of the General Meeting, i.e. on June 14, 2023, have the right to participate in the General Meeting of the Company, and in addition:
The Board of READ-GENE S.A. informs that following with Art. 401 Commercial Companies Code:
Under Art. 412 and 4121 ksh, a shareholder may participate in the General Meeting and exercise the right to vote in person or through a proxy. A power of attorney to participate in the General Meeting and exercise voting rights must be granted in writing or electronically. Granting a power of attorney in electronic form does not require a secure electronic signature verified with a valid qualified certificate.
The Company should be notified about granting a power of attorney in electronic form using electronic means of communication in the form of information sent by e-mail to the following address: office@read-gene.com , attaching a power of attorney in PDF form, and in the case of a shareholder or proxy who is not a natural person, an excerpt from the relevant register from the last 3 months.
The form containing the power of attorney template is available on the Company's website in the Investor Relations - General Meeting tab.
After arriving at the General Meeting:
A proxy who is a natural person and has been granted a power of attorney in electronic form by the principles set out above, or a person representing a proxy who is not a natural person and has been granted a power of attorney in electronic form under the rules set out above, should present proof of identity upon arrival at the General Meeting.
The Company makes available on the Company's website www.read-gene.com a form allowing for the exercise of voting rights by a proxy. The use of the template is not obligatory, it is only a guide as to the content.
The Company's Articles of Association do not provide for the possibility of participating in the General Meeting using electronic means of communication.
The Company's Articles of Association do not provide for the possibility of speaking during the General Meeting using electronic means of communication.
The Company does not provide for the possibility of exercising voting rights by correspondence or using electronic means of communication.
The documentation to be presented to the General Meeting together with draft resolutions will be posted on the Company's website www.read-gene.com from the date of convening the General Meeting.
Information regarding the General Meeting is available on the website www.read-gene.com
The list of Shareholders entitled to participate in the General Meeting of READ-GENE S.A. with its registered office in Szczecin will be available at the company's office in Grzepnica at ul. Alabastrowa 8, three business days before the General Meeting, i.e. on June 27, 2023 - June 29, 2023, from 8:00 a.m. to 4:00 p.m.
Persons entitled to participate in the Meeting will be able to register and receive a voting card directly in the Meeting room one hour before the start of the meeting.
Documents
Jan Lubiński – Prezes Zarządu
Announcement of the convening of the Ordinary General Meeting of Shareholders of READ-GENE S.A. as of June 30, 2023
The Board of READ-GENE S.A. with its registered office in Szczecin informs that it has decided to convene on the following day June 30, 2023, at 15:00 Ordinary General Meeting of Shareholders, which will take place in Szczecin at ul. 3 Maja 8/1 – Notary Office of Dobrosława Anna Kuniewicz.
The agenda of the Ordinary General Meeting of Shareholders will include:
Additional information
The Board of READ-GENE S.A. informs that by Art. 4061 – 4063 of the Commercial Companies Code, only persons who are shareholders of the Company sixteen days before the date of the General Meeting, i.e. on June 14, 2023, have the right to participate in the General Meeting of the Company, and in addition:
The Board of READ-GENE S.A. informs that following with Art. 401 Commercial Companies Code:
Under Art. 412 and 4121 ksh, a shareholder may participate in the General Meeting and exercise the right to vote in person or through a proxy. A power of attorney to participate in the General Meeting and exercise voting rights must be granted in writing or electronically. Granting a power of attorney in electronic form does not require a secure electronic signature verified with a valid qualified certificate.
The Company should be notified about granting a power of attorney in electronic form using electronic means of communication in the form of information sent by e-mail to the following address: office@read-gene.com , attaching a power of attorney in PDF form, and in the case of a shareholder or proxy who is not a natural person, an excerpt from the relevant register from the last 3 months.
The form containing the power of attorney template is available on the Company's website in the Investor Relations - General Meeting tab.
After arriving at the General Meeting:
A proxy who is a natural person and has been granted a power of attorney in electronic form by the principles set out above, or a person representing a proxy who is not a natural person and has been granted a power of attorney in electronic form under the rules set out above, should present proof of identity upon arrival at the General Meeting.
The Company makes available on the Company's website www.read-gene.com a form allowing for the exercise of voting rights by a proxy. The use of the template is not obligatory, it is only a guide as to the content.
The Company's Articles of Association do not provide for the possibility of participating in the General Meeting using electronic means of communication.
The Company's Articles of Association do not provide for the possibility of speaking during the General Meeting using electronic means of communication.
The Company does not provide for the possibility of exercising voting rights by correspondence or using electronic means of communication.
The documentation to be presented to the General Meeting together with draft resolutions will be posted on the Company's website www.read-gene.com from the date of convening the General Meeting.
Information regarding the General Meeting is available on the website www.read-gene.com
The list of Shareholders entitled to participate in the General Meeting of READ-GENE S.A. with its registered office in Szczecin will be available at the company's office in Grzepnica at ul. Alabastrowa 8, three business days before the General Meeting, i.e. on June 27, 2023 - June 29, 2023, from 8:00 a.m. to 4:00 p.m.
Persons entitled to participate in the Meeting will be able to register and receive a voting card directly in the Meeting room one hour before the start of the meeting.
Documents
Jan Lubiński – Prezes Zarządu
Announcement of the convening of the Ordinary General Meeting of Shareholders of READ-GENE S.A. as of June 30, 2023
The Board of READ-GENE S.A. with its registered office in Szczecin informs that it has decided to convene on the following day June 30, 2023, at 15:00 Ordinary General Meeting of Shareholders, which will take place in Szczecin at ul. 3 Maja 8/1 – Notary Office of Dobrosława Anna Kuniewicz.
The agenda of the Ordinary General Meeting of Shareholders will include:
Additional information
The Board of READ-GENE S.A. informs that by Art. 4061 – 4063 of the Commercial Companies Code, only persons who are shareholders of the Company sixteen days before the date of the General Meeting, i.e. on June 14, 2023, have the right to participate in the General Meeting of the Company, and in addition:
The Board of READ-GENE S.A. informs that following with Art. 401 Commercial Companies Code:
Under Art. 412 and 4121 ksh, a shareholder may participate in the General Meeting and exercise the right to vote in person or through a proxy. A power of attorney to participate in the General Meeting and exercise voting rights must be granted in writing or electronically. Granting a power of attorney in electronic form does not require a secure electronic signature verified with a valid qualified certificate.
The Company should be notified about granting a power of attorney in electronic form using electronic means of communication in the form of information sent by e-mail to the following address: office@read-gene.com , attaching a power of attorney in PDF form, and in the case of a shareholder or proxy who is not a natural person, an excerpt from the relevant register from the last 3 months.
The form containing the power of attorney template is available on the Company's website in the Investor Relations - General Meeting tab.
After arriving at the General Meeting:
A proxy who is a natural person and has been granted a power of attorney in electronic form by the principles set out above, or a person representing a proxy who is not a natural person and has been granted a power of attorney in electronic form under the rules set out above, should present proof of identity upon arrival at the General Meeting.
The Company makes available on the Company's website www.read-gene.com a form allowing for the exercise of voting rights by a proxy. The use of the template is not obligatory, it is only a guide as to the content.
The Company's Articles of Association do not provide for the possibility of participating in the General Meeting using electronic means of communication.
The Company's Articles of Association do not provide for the possibility of speaking during the General Meeting using electronic means of communication.
The Company does not provide for the possibility of exercising voting rights by correspondence or using electronic means of communication.
The documentation to be presented to the General Meeting together with draft resolutions will be posted on the Company's website www.read-gene.com from the date of convening the General Meeting.
Information regarding the General Meeting is available on the website www.read-gene.com
The list of Shareholders entitled to participate in the General Meeting of READ-GENE S.A. with its registered office in Szczecin will be available at the company's office in Grzepnica at ul. Alabastrowa 8, three business days before the General Meeting, i.e. on June 27, 2023 - June 29, 2023, from 8:00 a.m. to 4:00 p.m.
Persons entitled to participate in the Meeting will be able to register and receive a voting card directly in the Meeting room one hour before the start of the meeting.
Documents
Jan Lubiński – Prezes Zarządu
Read-Gene S.A. © 2021 | Regulamin Strony | Polityka prywatności | Projekt i realizacja: Market Link
Read-Gene S.A. © 2021 | Regulamin Strony | Polityka prywatności | Projekt i realizacja: Market Link